<VariationArchive RecordType="classified" VariationID="832363" VariationName="NC_000016.10:g.(?_87888109)_(87891974_?)del" VariationType="Deletion" Accession="VCV000832363" Version="6" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-11" DateCreated="2020-04-15" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="820899" VariationID="832363">
      <GeneList>
        <Gene Symbol="CA5A" FullName="carbonic anhydrase 5A" GeneID="763" HGNC_ID="HGNC:1377" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q24.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="87881549" stop="87936529" display_start="87881549" display_stop="87936529" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="87921624" stop="87970111" display_start="87921624" display_stop="87970111" Strand="-" />
          </Location>
          <OMIM>114761</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000016.10:g.(?_87888109)_(87891974_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q24.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" innerStart="87921715" innerStop="87925580" display_start="87921715" display_stop="87925580" variantLength="3866" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.(?_87921715)_(87925580_?)del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.(?_87921715)_(87925580_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000016.10:g.(?_87888109)_(87891974_?)del AND Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency" Accession="RCV001032853" Version="6">
        <ClassifiedConditionList TraitSetID="13511">
          <ClassifiedCondition DB="MedGen" ID="C3810404">Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-12" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24530203</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26913920</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13511" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18709" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Carbonic anhydrase VA deficiency, hyperammonemia due to</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency</ElementValue>
                <XRef ID="MONDO:0014332" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CA5AD</ElementValue>
                <XRef Type="MIM" ID="615751" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13201" />
                <XRef ID="13201" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Most children with carbonic anhydrase VA (CA-VA) deficiency reported to date have presented between day 2 of life and early childhood (up to age 20 months) with hyperammonemic encephalopathy (i.e., lethargy, feeding intolerance, weight loss, tachypnea, seizures, and coma). Given that fewer than 20 affected individuals have been reported to date, the ranges of initial presentations and long-term prognoses are not completely understood. As of 2021 the oldest known affected individual is an adolescent. Almost all affected individuals reported to date have shown normal psychomotor development and no further episodes of metabolic crisis; however, a few have shown mild learning difficulties or delayed motor skills.</Attribute>
                <XRef ID="NBK284774" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25834911</ID>
                <ID Source="BookShelf">NBK284774</ID>
              </Citation>
              <XRef ID="401948" DB="Orphanet" />
              <XRef ID="C3810404" DB="MedGen" />
              <XRef ID="MONDO:0014332" DB="MONDO" />
              <XRef Type="MIM" ID="615751" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2357416" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="NM_001739.1_16_Deletion (exons 6-7)|MedGen:C3810404" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001196160" DateUpdated="2023-11-11" DateCreated="2020-04-15" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24530203</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26913920</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 6-7 of the CA5A gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. This variant has not been reported in the literature in individuals affected with CA5A-related conditions. The region of the CA5A gene that includes exon(s) 6 has been determined to be clinically significant (PMID: 24530203, 26913920). Therefore, deletions that encompass that region are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CA5A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.(?_87921715)_(87925580_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3810404" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2357416" TraitType="Disease" MappingType="XRef" MappingValue="C3810404" MappingRef="MedGen">
        <MedGen CUI="C3810404" Name="Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

